-
Best Stocks: Regions Financial Corporation (NYSE:RF), CEMEX, (NYSE:CX), Adobe Systems Incorporated (NASDAQ:ADBE), Albany Molecular Research (NASDAQ:AMRI), Cornerstone Strategic Value Fund Inc. (NYSEMKT:CLM)
Regions Financial Corp (NYSE:RF)‘s stock had its “neutral” rating reaffirmed by Zacks in a research note issued on Tuesday. They currently have a $10.50 price objective on the stock. Zacks‘s price target indicates a potential upside of 5.85% from the stock’s previous close. Regions Financial Corporation (NYSE:RF) in last trading activity advanced 3.02% to close…
-
Traders Should Watch: Albany Molecular Research (NASDAQ:AMRI), Alcatel Lucent (NYSE:ALU), MFRI (NASDAQ:MFRI), Rosetta Stone (NYSE:RST), Peoples Bancorp (NASDAQ:PEBK)
Albany Molecular Research (NASDAQ:AMRI) major shareholder Ambra Constance M. D unloaded 20,000 shares of the company’s stock on the open market in a transaction that occurred on Wednesday, December 10th. The stock was sold at an average price of $16.24, for a total value of $324,800.00. Following the completion of the sale, the insider now…
-
Stocks to Watch: Albany Molecular Research Inc. (NASDAQ:AMRI), Merck & Co. Inc. (NYSE:MRK), Sagent Pharmaceuticals (NASDAQ:SGNT), Diversified Restaurant (NASDAQ:BAGR), PGT (NASDAQ:PGTI)
Albany Molecular Research Inc. (NASDAQ:AMRI) major shareholder Ambra Constance M. D sold 20,000 shares of the company’s stock in a transaction dated Wednesday, December 10th. The stock was sold at an average price of $16.24, for a total value of $324,800.00. Following the sale, the insider now directly owns 2,535,818 shares of the company’s stock,…
-
Traders Should Watch: Albany Molecular Research Inc. (NASDAQ:AMRI), Oncothyreon Inc (NASDAQ:ONTY), AtriCure (NASDAQ:ATRC), Coach (NYSE:COH), Ashford Hospitality Prime (NYSE:AHP)
Albany Molecular Research (NASDAQ:AMRI) major shareholder Ambra Constance M. D sold 20,000 shares of the company’s stock in a transaction dated Wednesday, December 10th. The stock was sold at an average price of $16.24, for a total value of $324,800.00. Following the sale, the insider now directly owns 2,535,818 shares of the company’s stock, valued…
-
News Buzz: Yahoo! Inc. (NASDAQ:YHOO), Points International (NASDAQ:PCOM), Infosys (NYSE:INFY), Google Inc (NASDAQ:GOOG), Albany Molecular Research Inc. (NASDAQ:AMRI)
On 20 November Yahoo! Inc. (NASDAQ:YHOO) said it will supplant Google’s search engine on Firefox’s Web browser in the U.S., signalling Yahoo’s resolve to regain some of the ground that it has lost in the most lucrative part of the Internet’s ad market. Yahoo! Inc. (NASDAQ:YHOO) in last trading activity advanced 0.26% to close at…
-
Top News: Denbury Resources Inc. (NYSE:DNR), Noble Corp. (NYSE:NE), Coca-Cola Bottling Co. Consolidated (NASDAQ:COKE), Zafgen (NASDAQ:ZFGN), Albany Molecular Research Inc. (NASDAQ:AMRI)
Denbury Resources Inc. (NYSE:DNR) Board of Directors has declared a quarterly cash dividend of $0.0625 per common share, a rate of $0.25 per share on an annualized basis, payable Dec. 30, 2014, to shareholders of record as of the close of business on Nov. 25, 2014. Denbury Resources Inc. (NYSE:DNR) in last trading activity moved…
-
Active Watch List: Philip Morris International (NYSE:PM), Synacor (NASDAQ:SYNC), Albany Molecular Research Inc. (NASDAQ:AMRI), Allscripts Healthcare Solutions (NASDAQ:MDRX), DISH
Zacks lowered shares of Philip Morris International Inc (NYSE:PM) from a neutral rating to an underperform rating in a research report released on Wednesday morning. Zacks currently has $80.00 price objective on the stock. Philip Morris International, Inc. (NYSE:PM) in last trading activity decreased -1.80% to close at $86.28. Company weekly performance is -2.09% while…
-
Hot News: Synageva BioPharma Corp. (NASDAQ:GEVA), Albany Molecular Research Inc. (NASDAQ:AMRI), United Security Bancshares Inc. (NASDAQ:USBI), Snyder’s-Lance (NASDAQ:LNCE), DPS
Synageva Biopharma Corp (NASDAQ:GEVA) CFO Carsten Boess unloaded 25,404 shares of the stock on the open market in a transaction that occurred on Thursday, October 30th. The stock was sold at an average price of $80.10, for a total value of $2,034,860.40. Synageva BioPharma Corp. (NASDAQ:GEVA) in last trading activity moved down -9.18% to close…
-
Biotech Losers: Celldex Therapeutics (NASDAQ:CLDX), Albany Molecular Research Inc. (NASDAQ:AMRI), Novavax (NASDAQ:NVAX), Sequenom Inc. (NASDAQ:SQNM), Merrimack Pharmaceuticals (NASDAQ:MACK)
Celldex Therapeutics Inc., (NASDAQ:CLDX) a New Jersey company with Needham and Fall River sites, plunged on news a trial of its cancer drug CDX-011 will last longer than expected. It’s testing the drug in patients with a hard-to-treat form of breast cancer, but “eligibility criteria are limiting [researchers’] ability to enroll patients.” Celldex will amend…